ClinicalTrials.gg
RecruitingNCT07448571Updated Mar 4, 2026

Evaluation of Revitalization Success Using i-PRF in Non-Surgical Root Canal Retreatment

An interventional study of Non-Surgical Root Canal Retreatment and Regenerative Endodontic Treatment in Apical Periodontitis and Periapical Diseases, sponsored by Marmara University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-03-04.

Sponsored by Marmara University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Registered 9 months after the study started (first participant enrolled May 2025, registered Feb 2026).
  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 81 studies in Periapical Periodontitis with a site in Turkey — 13 open to participants now, 20 under way, none of them phase 3. Periapical Periodontitis · Turkey.

Planned enrollment
10th of 75
140 · median 66
Started
2025
with 14 others
No phase
73 of 81
11 open now
Primary completion
2026-06
later than 7 of 19 live
Registered
60th of 81
by date
Lead sponsor
3 of 81
Marmara University

Among the 81 studies in Periapical Periodontitis with a site in Turkey, this one is the 10th largest by planned enrollment of the 75 interventional ones that give a count, is one of 15 that started in 2025, is one of 73 with no phase, reaches primary completion later than 7 of the 19 other live ones, and was the 60th registered.

Periapical Periodontitis

281 studies on the registry are indexed under Periapical Periodontitis; 79 are open to participants now.

Browse Periapical Periodontitis studies →

Open to participants now

13 of the 81 studies in Periapical Periodontitis with a site in Turkey are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 43 Periapical Periodontitis studies recruiting now, 17 (40%) set no upper age limit and 25 (58%) stop at 75 or younger; 5 take children under 18; 21 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Periapical Periodontitis with a site in Turkey, or all of them as a file.
02

Study summary

The goal of this randomized controlled clinical trial is to determine whether regenerative endodontic treatment can improve healing outcomes in teeth with apical periodontitis following failed root canal treatment. The study includes adult patients who require non-surgical root canal retreatment due to persistent periapical lesions.

The main questions it aims to answer are:

Does regenerative endodontic treatment improve periapical healing compared with conventional non-surgical root canal retreatment? Does regenerative treatment increase long-term treatment success and tooth survival? Researchers will compare conventional non-surgical root canal retreatment with regenerative endodontic treatment using injectable platelet-rich fibrin (i-PRF) to see if the regenerative approach results in better clinical and radiographic outcomes.

Participants will:

Be randomly assigned to receive either conventional retreatment or regenerative endodontic treatment.

Undergo clinical and radiographic evaluations over a two-year follow-up period. Be assessed for pain, sensitivity, pulp vitality, hard tissue formation, and periapical healing.

Read the detailed description

Apical periodontitis is a common consequence of failed root canal treatment and is primarily associated with persistent intraradicular infection. Although non-surgical root canal retreatment remains the standard treatment approach for failed primary endodontic therapy, reported failure rates range between 23% and 30%. Even after thorough chemomechanical preparation, complete elimination of microorganisms may not always be achieved. In addition, conventional treatment does not restore pulp vitality and may compromise the structural integrity of the remaining tooth tissue.

Regenerative endodontic procedures have emerged as a biologically based alternative aimed at promoting tissue regeneration within the root canal system. By utilizing biological scaffolds and growth factor-rich preparations, regenerative therapy may enhance healing, support revascularization, and potentially restore natural defense mechanisms of the tooth.

This study is designed as a randomized controlled clinical trial comparing conventional non-surgical root canal retreatment with regenerative endodontic treatment. The regenerative protocol incorporates injectable platelet-rich fibrin (i-PRF), an autologous blood-derived biomaterial obtained through low-speed centrifugation. i-PRF contains growth factors and bioactive components that may support angiogenesis, cell migration, and tissue repair.

Following local anesthesia and rubber dam isolation, previously obturated root canal fillings will be removed. Standardized chemomechanical preparation and irrigation protocols will be performed according to the assigned treatment group. In the regenerative group, i-PRF will be applied as a biological scaffold prior to placement of a bioceramic material to achieve coronal sealing. In the conventional retreatment group, canals will be obturated using established root canal filling techniques.

All procedures will be performed under standardized clinical conditions. Radiographic examinations will be obtained using positioning devices to ensure reproducibility and standardization of angulation. Patients will be monitored periodically over a two-year follow-up period to assess healing progression and treatment outcomes.

This study seeks to provide evidence regarding the biological and clinical potential of regenerative endodontic therapy as an alternative to conventional retreatment in teeth with persistent apical periodontitis.

03

Conditions studied

  • Apical Periodontitis
  • Periapical Diseases

Keywords

  • apical periodontitis
  • root canal retreatment
  • regenerative endodontic treatment
  • Injectable Platelet-Rich Fibrin
  • Non-Surgical Endodontic Retreatment
  • Periapical Healing
  • Randomized Controlled Trial
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged between 18 and 50 years.
  • Single-rooted maxillary anterior teeth with closed apices.
  • Presence of periapical lesion confirmed radiographically.
  • Previously treated root canal tooth requiring non-surgical retreatment.
  • Tooth has not previously undergone non-surgical root canal retreatment.
  • Tooth is considered restorable.
  • Patient is systemically healthy.
  • Patient is willing to participate and provides .

Exclusion criteria

Exclusion Criteria:

  • Teeth without radiographic evidence of periapical lesion.
  • Teeth with developmental anomalies.
  • Patients with systemic diseases that may affect healing.
  • Pregnant patients.
  • Teeth presenting with internal or external root resorption.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • Active comparator
    Conventional Non-Surgical Root Canal Retreatment

    Participants will receive conventional non-surgical root canal retreatment.

    Procedure: Non-Surgical Root Canal Retreatment

  • Experimental
    Regenerative Endodontic Treatment With Injectable Platelet-Rich Fibrin

    Participants will receive regenerative endodontic treatment using injectable platelet-rich fibrin as a biological scaffold.

    Procedure: Regenerative Endodontic Treatment

Interventions

  • ProcedureNon-Surgical Root Canal Retreatment

    Conventional non-surgical root canal retreatment will be performed under local anesthesia and rubber dam isolation. Previous root canal filling materials will be removed, followed by standardized chemomechanical preparation and irrigation. The canals will be obturated using resin-based sealer and gutta-percha with lateral condensation technique, and the tooth will be restored with a permanent coronal restoration.

  • ProcedureRegenerative Endodontic Treatment

    Regenerative endodontic treatment will be performed under local anesthesia and rubber dam isolation. After removal of previous root canal filling materials and standardized canal preparation, injectable platelet-rich fibrin obtained from the patient's autologous blood will be applied into the canal space as a biological scaffold. Mineral trioxide aggregate will be placed coronally, followed by permanent composite restoration.

06

What researchers measure

Primary outcomes

  1. Change in Periapical Index (PAI) Score

    Periapical healing will be assessed using standardized periapical radiographs and scored according to the Periapical Index (PAI) system. Changes in lesion size and PAI scores from baseline to follow-up visits over a 24-month period will be evaluated.

    Time frame: Baseline and up to 24 months

Secondary outcomes

  1. Postoperative Pain Intensity

    Postoperative pain intensity will be assessed at follow-up visits using clinical evaluation and patient-reported outcomes when applicable.

    Time frame: Baseline and up to 24 months

  2. Percussion and Palpation Sensitivity

    Clinical evaluation of percussion and palpation sensitivity will be performed at scheduled follow-up visits to assess signs of persistent inflammation or tenderness.

    Time frame: Baseline and up to 24 months

  3. Pulp Vitality Response

    Pulp vitality will be assessed using standardized vitality testing methods during follow-up visits to determine restoration of tooth vitality.

    Time frame: Baseline and up to 24 months

  4. Proportion of Teeth With Successful Healing (PAI ≤ 2)

    Successful healing will be defined as a Periapical Index (PAI) score of 2 or lower at follow-up evaluations. The proportion of teeth achieving successful healing within 24 months will be compared between treatment groups.

    Time frame: Baseline and up to 24 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Jun 2026, 13 months after the start.

Of 172 non-industry interventional studies with no phase under Periapical Periodontitis, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 19. This study's planned 13 months is close to that.

Counting every sponsor, half of 173 studies reached it within 12 months; a quarter within 6 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2026
First posted
Mar 4, 2026
StartActual
May 1, 2025
Primary completionEst.
Jun 1, 2026
CompletionEst.
Dec 1, 2027
Last update
Mar 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07448571
Lead sponsor
Marmara University
Responsible party
Melike Beyza Kaplanoğlu (Research Assistant, Marmara University) — Principal investigator
First posted
Mar 4, 2026
Start date
May 1, 2025
Primary completion
Jun 1, 2026 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Mar 4, 2026

Study contacts

Melike B KAPLANOGLU
Contact
melikekaplanoglu37@gmail.com
905319330396
Idil OZDEN, PhD
Contact
idil.akman94@gmail.com
Idil OZDEN, PhD
study chair · Marmara University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion